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Control of gene expression is a basic regulatory mechanism 
of living organisms. In microorganisms, glucose or other rap- 
idly metabolizable carbon sources repress the expression of 
genes that code for enzymes related to the metabolism of 
other carbon sources. This phenomenon, known as catabolite 
repression, allows microorganisms to cope effectively with 
changes in the carbon sources present in their environment. 
In the case of Escherichiu coli, a model to explain at the 
molecular level the mechanism of catabolite repression has 
been worked out (Ullmann, 1985; Saier, 1989), although some 
of its elements remain unidentified. 
Yeasts are also subject to carbon catabolite repression but 
the underlying mechanism(s) is less understood than it is in E. 
coli and we do not yet know how glucose exerts its repressive 
effect. In the present article I will review information gathered 
in the last few years on a variety of catabolite-repressible 
systems, try to integrate it and to elaborate a scheme for 
carbon catabolite repression consistent with the results 
obtained. Although this review will be centered around Sac- 
churomyces cerevisiue, reference to other yeast species will be 
made when information is available. 
The degree of repression caused by glucose depends 
strongly on the enzyme affected and the strain used. As shown 
in Table 1, it can vary from about 800-fold for invertase 
to less than 10-fold for aconitase, cytochrome c oxidase or 
isocitrate dehydrogenase. In most cases, the decrease in en- 
zyme levels caused by glucose is paralleled by a decrease in 
the concentration of the corresponding mRNA. This could be 
due to an effect of glucose either on the rate of transcription, 
or on the stability of the corresponding mRNA or on both. 
Direct measurements of transcription rates have been 
performed in only a few cases. For the genes CYCI, encoding 
iso-1 cytochrome c, and MAL6S, encoding maltase, it was 
found that derepressed cells synthesized the corresponding 
mRNAs 6 times and 15 times faster, respectively, than re- 
pressed cells (Zitomer et al., 1979; Federoff et al., 1983a). It 
should be noted that, in the case of maltase, an induction by 
maltose is superimposed on the process of catabolite re- 
pression, but even in the presence of maltose, the addition of 
glucose to a yeast culture causes an approximately I5-fold 
decrease in the rate of transcription of the MAL6S gene in 
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less than 20 min. It is noteworthy that glucose also affects the 
stability of the mRNAs corresponding to the genes mentioned. 
The half-life of the CYCl mRNA in derepressed cells is about 
12 min (Zitomer et al., 1979), while it decreases to about 2 min 
in the presence of glucose (Zitomer and Nichols, 1978). In the 
case of maltase, the half-life of the corresponding mRNA 
decreases from 25 min to 6 min upon glucose addition 
(Federoff et al., 1983 b). It appears therefore that, at least for 
certain genes, glucose affects both DNA transcription and 
mRNA stability. However, since there are no data on the 
factors which affect mRNA stability differentially, I will deal 
only with the effects of glucose on the rate of transcription of 
a variety of genes. 
It can be noted that in S. cerevisiue and some other yeasts 
the presence of glucose can affect enzyme levels, not only 
through a decrease in the transcription rate but also through 
an increase in the degradation rate of the corresponding pro- 
teins. This last process is known as catabolite inactivation; it 
appears to be restricted to a limited number of enzymes and 
its underlying mechanism has not yet been unravelled 
(Gancedo and Serrano, 1989; Chiang and Schekman, 1991). 
THE ELEMENTS OF THE SYSTEM 
The process of repression is initiated in response to a signal 
which is formed when glucose or related sugars are present in 
the medium. The formation of this signal requires the activity 
of one or more proteins and the signal must be received and 
transduced to slow down or stop the transcription of the 
affected gene(s). The signal produced by glucose is not likely 
to interact directly with DNA but instead could act by altering 
the conformation of a regulatory protein, through either an 
allosteric or a covalent modification. As shown in Fig. 1 the 
regulatory protein(s), which respond to the glucose signal, 
could affect directly the transcription of the regulated gene 
or act on another regulatory gene originating a regulatory 
cascade. The repression mechanism would require at least 
three elements: the signal produced by glucose, a protein 
coded by a trans-acting regulatory gene, and a cis-acting el- 
ement located in the promoter of the regulated gene, able to 
respond to the protein coded by the regulatory gene. Control 
by glucose could be positive or negative, that is glucose could 
activate a repressing protein or could inhibit an activating 
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Table 1. Repression of yeast enzymes by glucose. 
Enzyme Specific activity 
- Glc + Glc 
-. - 
Repression Reference 
factor 
lnvertasc 
Alcohol dehydrogenase 
Maltase 
Malate synthase 
lsocitrate dehydrogenasc ( N  ADP) 
f'hosphorrrolpyruvate carboxykinase 
Fructose 1.6-bisphosphatase 
Isocitrate lyase 
Galactokinase" 
Glutamate dehydrogenase (NAD) 
Aconitase 
Cyst c oxidase 
lsocitrate dehydrogenase (NAD) 
130 
1850 
180 
82 
214 
300 
50 
10 
40 
190 
935 
11 
75 
mlJjmg protein 
- 
< 0.2 
15 
2 
< 1  
26 
< 5  
< l  
< 0.2 
1 
I 
170 
2 
18 
750 
120 
YO 
80 
80 
60 
50 
50 
40 
25 
5 
5 
4 
Estruch & Carlson 1990a 
Williamson et al. 1981 
Entian & Zimmermann 1982 
Polakis & Bartley 1965 
Polakis & Bartley 1965 
Gancedo & Schwerzmann 1976 
Gancedo & Gancedo 1971 
Eraso & Gancedo 1984 
Torchia et al. 1984 
Polakis & Bartley 1965 
Polakis & Bartley 1965 
Eraso & Gancedo 1984 
Polakis & Bartley 1965 
a Relative values are given. 
Glucose 
Regulated gene 
@- - 
"Signal" 
Fig. 1. Simplified scheme for the regulation of a gene subject to 
catabolite repression. Genes 1 ,  2. 3 and 4 are trans-acting genes impli- 
cated at different levels in the control of the regulated gene. The 
product of gene 1 is necessary for the formation of the signal derived 
from glucose. This signal interacts with the products of genes 2 and/ 
or 3 and slows down the transcription of the regulated gene either by 
activation of repressing proteins or by inhibition of activating pro- 
teins. I n  the first case the products ofgenes 3 and 4 are transcriptional 
inhibitors and the signal activates the product of gene 3 and/or acti- 
vates the transcription of gene 4. In the second case the products of 
genes 3 and 4 are transcriptional activators and the signal inhibits the 
product o f  gene 3 and/or inhibits the transcription of gene 4. Hatched 
boxes represent the promoter regions of the corresponding genes. 
protein. Trws-acting regulatory genes affecting catabolite re- 
pression could act at  different levels as shown on Fig. 1 : they 
could code for proteins involved in the formation of the signal 
(gene 1 ) .  for proteins which interact with other regulatory 
genes (gene 2 )  or  for proteins which interact with the regulated 
gene itself (genes 3 o r  4). 
THE SIGNAL 
Catabolite repression can be exerted not only by the three 
related sugars glucose, mannose and fructose, but also by 
other types of sugars like galactose (Polakis and Bartley, 1965) 
or maltose (Eraso and Gancedo, 1984). The fact that some 
genes are repressed by all these sugars while others are only 
affected by glucose should be taken into account in any dis- 
cussion about the signal involved in catabolite repression. 
At least two possibilities may be contemplated: (a) glucose 
produces different signals, each of them specific for a certain 
set of genes, while maltose or galactose produce or mimick 
only some of these signals and therefore affect only a limited 
set of genes; (b) all sugars produce only one (and the same) 
signal but galactose or maltose produce a weaker signal than 
glucose and only a limited set of genes respond to this weaker 
signal. 
By analogy with the situation in E.  coli, it was thought that 
the signal produced by the repressing sugars was a decrease in 
the concentration of internal CAMP. However several lines of 
evidence indicate that, in yeast, catabolite repression is not 
associated with a low level of CAMP. In a mutant permeable 
to CAMP, the addition of exogenous cAMP did not prevent 
glucose repression of galactokinase synthesis (Matsumoto et 
al., 1982) and in different yeasts intracellular concentrations 
of cAMP are higher in the presence of glucose and other 
sugars than in derepressed conditions (Eraso and Gancedo, 
1984). Results from strains lacking adenylate cyclase suggest 
that, in S. certvisiae, cAMP itself does not play a critical role 
in catabolite repression (Matsumoto et al., 1983a) although 
cAMP may be necessary for the transcription of certain genes 
like SUC2 (Matsumoto et al., 1984). However, cAMP appears 
to be specifically involved in the transcriptional repression of 
the gene A D H 2  encoding alcohol dehydrogenase 11. Tran- 
scription of this gene is dependent on the presence of the active 
form of the transcription activator ADRI .  Phosphorylatcd 
ADRI is inactive and therefore alcohol dehydrogenase I 1  
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derepression is impaired in bcyl mutants where the protein 
kinases encoded by TPKl or TPK2 are always active (Cherry 
et al., 1989). In contrast, alcohol dehydrogenase I1 partially 
escapes glucose repression in a cyrl mutant having a tempera- 
ture-sensitive adenylate cyclase (K. Dombek, cited in Taylor 
and Young, 1990). Since this situation is the opposite of that 
of SUC2, which cannot be derepressed in such a mutant, it 
may be concluded that cAMP does not have a uniform effect 
on different genes subject to catabolite repression. 
In Schizosaccharomyces pombe catabolite repression could 
also in some cases occur through a CAMP-signaling pathway. 
In Sch. pombe mutants affected in the gene git2 encoding 
adenylate cyclase, the gene f l p l  encoding fructose 1,6-bis- 
phosphatase is derepressed in the presence of glucose and 
external cAMP abolishes this derepression. However the 
derepression is observed even with git2 alleles which do not 
cause a marked change in steady-state cAMP levels (Hoffman 
and Winston, 1991). The reason for the absence of repression 
in these particular git2 mutants is not entirely clear. 
The use of glycolytic mutants (Gancedo J. M., unpublished 
results) and of non-metabolizable glucose analogues (Witt et 
al., 1966; Gancedo and Gancedo, 1985) indicates that exten- 
sive metabolism of the sugar is not necessary for the ‘glucose 
signal’ to be produced. The only requirement appears to be 
the presence of a kinase able to phosphorylate the sugar, and 
this suggests a possible role for glucose 6-phosphate. However, 
it should be taken into account that a functional kinase is 
not only required for phosphorylation but also controls the 
transport of the corresponding sugar (Bisson and Fraenkel, 
1983). Therefore, it remains possible that the lack of catabolite 
repression in the absence of a kinase is related to an alteration 
in the binding of the sugar to the membrane rather than to 
the absence of phosphorylation itself. Up to now, no clear 
evidence exists on the nature of the signal(s) produced by 
glucose. 
THE INTERMEDIARY ELEMENTS 
These elements are the products of the trans-acting regula- 
tory genes which have been introduced in the second section. 
The existence of these intermediary elements has been revealed 
by studies on mutants affected in catabolite repression. These 
mutants belong to two basic types, non-repressible and non- 
derepressible (for a review see Gancedo and Gancedo, 1986; 
Entian, 1986). A large number of such mutants has been 
isolated by different groups and that raised the problem of 
establishing which mutations were allelic, since their proper- 
ties were often similar. Comparison between mutants is further 
complicated by the fact that the effect of a specific mutation 
depends in some cases on the genetic background. Cloning 
and sequencing of the corresponding genes in the last few 
years has allowed a definite identification of many of the 
mutations which have been reported. It was found that some 
of them had been isolated in more than one laboratory and 
named differently, adding confusion to the complexity of the 
field. An agreement on a unified nomenclature for catabolite 
repression mutants, as was reached for mutants related with 
general amino acid control (see Thireos et al., 1984), is ex- 
tremely desirable. The time is probably ripe for such an initia- 
tive since in a number of cases the mode of action of the 
products of the implicated genes is, at least partially, under- 
stood. 
Tables 2 and 3 present a list of mutations which, judged 
by their chromosomal localization or by comparison of the 
Table 2. Mutations which interfere with the derepression of certain genes 
in Sacchavomyces cevevisiae. References for each mutation are given 
in the text 
Chromosomal Size of the protein Name of the 
mutation location coded by the gene 
catl = ccrl = snfl 
cut3 = snf4 
hap2 
hap3 
hap4 
sn f 2  
sn f 5  
snf6 
msn I 
kDa 
IV, distal to rna3 12 
36 
VII, proximal to ade5 29 
16 
62 
xv 194 
I1 102 
58 
43 
- 
- 
- 
- 
- 
sequence of the corresponding genes, are non-allelic. In the 
following I will review the characteristics of the genes involved 
in catabolite repression whose products have been charac- 
terized to some extent. I will utilize in each case the designation 
given by the group that first described the mutation; ‘syn- 
onyms’ appear in Tables 2 and 3 and in brackets in the text 
when the mutation is mentioned for the first time. 
Intermediary elements necessary for derepression 
CATI (CCR1, SNFI) ,  CAT3 (SNF4) 
The products of the genes CATI and CAT3 appear to act 
together. Cat1 mutants were isolated as unable to grow on 
glycerol or maltose (Zimmermann et al., 1977) or on ethanol 
(Ciriacy, 1977); in the latter case the mutation received the 
name ccrl. Later cat3 and additional catl mutants were iso- 
lated by Entian and Zimmermann (1982). Mutants snfI and 
snf4, isolated originally as unable to ferment sucrose or raffi- 
nose (Neigeborn and Carlson, 1984), were found to be allelic 
to catl and cat3, respectively. 
CATl encodes a protein of 633 amino acids with 14 histi- 
dine residues between positions 18 and 32 (Celenza and 
Carlson, 1986). This histidine tract is, however, dispensable for 
function (Celenza and Carlson, 1989). The protein contains a 
region with similarity to the catalytic domains of mammalian 
protein kinases and to the product of the yeast gene CDC28. 
The CATl protein can be autophosphorylated, mostly on 
serine but also on threonine residues (Celenza and Carlson, 
1986). The protein kinase activity of CATl appears essential 
for its function since a mutated protein, where a lysine residue 
in the predicted ATP-binding site is replaced by an arginine, 
was not functional (Celenza and Carlson, 1989). No physio- 
logical substrate has yet been identified for CATl. Subcellular 
fractionation experiments suggest that a major part of CATl 
is either associated with membranes or otherwise insoluble 
(Celenza and Carlson, 1986). 
CAT3 encodes a protein of 322 amino acids without con- 
spicuous special features (Schuller and Entian, 1988 ; Celenza 
et al., 1989). A CAT3-P-galactosidase hybrid protein was 
found in the nuclear fraction (Schuller and Entian, 1988) but 
was also present in the cytoplasm (Celenza et al., 1989). The 
effects of the cat3 mutation can be alleviated by increased 
dosage of CAT1 or by different mutations in the coding region 
of CATI. In this situation SUC2 may be derepressed in the 
absence of a functional CAT3 but remains subject to catabolite 
repression. Therefore it has been concluded that the CAT3 
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Table 3. Mutations which eliminate catabolite repression of certain genes in Succhavomyces cerevisiue. References for each mutation are given 
in the text. 
Name of the mutation Chromosomal location Size of the protein 
coded by the gene 
kDa 
hex2 = reg1 IV, near trpl 114 
cat80 = grrl X, distal to cdcl l  133 
migl VII, between trp5 and rad6 56 
rgr I XII, between gal2 and pep3 123 
78 
hxk2 = hex1 = glrl VII, end link arm 55  
tupl =,flkl = umr7 = c.yc9 = arnml = slfz 
cycd = ssn6 11, near lys2 107 
IV, between thr4 and MAL2 
protein affects CAT1 positively without being absolutely re- 
quired for its function (Celenza and Carlson, 1989). The mech- 
anism of action of CAT3 remains unclear but there is evidence 
that the proteins CATl and CAT3 can interact (Celenza et al., 
1989; Fields and Song, 1989). CAT3 appears to function in 
part by stabilizing CATl and this effect is more critical at high 
temperatures but this is not its major role (Celenza et al., 
1989). It has been suggested that CAT3 could directly stimu- 
late the kinase activity of CAT1 or counteract a negative 
effector of the kinase; another possibility would be for CAT3 
to prevent the function of a phosphatase antagonistic to CATl 
(Celenza and Carlson, 1989). 
HAP2, HAP3, HAP4 
The products of the genes HAPZ, HAP3 and HAP4 appear 
to act in a concerted manner. Mutants hap2, hap3 and hap4 
were identified looking for colonies affected in the expression 
of the E. coli lac2 gene placed under the control of the UAS2 
activating sequence of the gene CYCI (Guarente et al., 1984; 
Hahn et al., 1988; Forsburg and Guarente, 1989). The corre- 
sponding genes have been cloned by complementation 
(Pinkham and Guarente, 1985; Hahn et al., 1988; Forsburg 
and Guarente, 1989). 
HAP2 encodes a protein of 265 amino acids from which 
a core region comprising amino acids 154 - 21 8 appears suf- 
ficient for function in vivo. The region between amino acids 
154 and 197 is both necessary and sufficient for association 
of the protein with the products of HAP3 and HAP4; in this 
region amino acids 180 - 184 appear relatively dispensable 
(Olesen and Guarente, 1990). The sequence 154 - 197 shows 
no similarity with structures previously described for 
heteromeric protein - protein interaction. The region 197 - 
218 appears essential for DNA-specific binding although it 
lacks similarity to other structures which bind DNA. The 
region located from residue 154 towards the amino terminal 
part increases the transcription rate of the CYCI-lacZ fusion 
gene but is not absolutely necessary. In this region a 
polyglutamine tract is located between residues 120 - 133. The 
carboxy-terminal region is highly basic with 27% of the resi- 
dues being either arginine or lysine (Pinkham et al., 1987). 
The HAP3 gene encodes two overlapping transcripts of 
0.57 and 3 kb that are read off from opposite strands. Using 
site-directed mutagenesis, it was found that from the possible 
proteins encoded by HAP3 only a 144-amino-acid protein 
encoded by the 0.57-kb transcript is essential for activating 
transcription (Hahn et al., 1988). The sequence of this protein 
does not show any characteristic feature. It is not yet clear 
whether the 3-kb mRNA has any role in HAP3 expression or 
function. 
The HAP2 and HAP3 proteins have been tagged by fusion 
to LexA and P-galactosidase, respectively. The fusion proteins 
copurify through four chromatographic steps, indicating that 
HAP2 and HAP3 can associate in the absence of DNA (Hahn 
and Guarente, 1988). It has been suggested (Hooft van 
Huijsduijnen et al., 1990) that the interface between HAP2 
and HAP3 could involve a tetrahedral metal coordination 
complex between a His-Xaa,-His motif from HAP2 and a 
Cys-Xaa,-Cys motif from HAP3. However, since the HAP2 
motif is found at positions 196-200 which are dispensable 
for HAPZHAP3 binding (Olesen and Guarente, 1990), the 
suggestion appears to be incorrect. 
HAP4 encodes a protein of 553 amino acids. It contains a 
very short basic region between residues 54 and 80, followed 
by an asparagine-rich tract. The carboxy-terminal region is 
extremely acidic, 30% of the residues between 424-471 and 
519 - 549 being acidic, and a truncated protein lacking the 
acidic carboxy-terminal domain is not active. A HAP4-GAL4 
fusion protein with residues 1 - 327 from HAP4 and the acidic 
activator region of GAL4 complemented a hap4 mutation. 
Therefore it appears that residues 1 - 327 allow the anchoring 
of HAP4 to the complex HAP2-HAP3 and the acidic end is 
a transcription activation domain (Forsburg and Guarente, 
1989). 
The three proteins HAP2, HAP3 and HAP4 are required 
to bind specifically to the corresponding promoters. Using 
size variants of these proteins, it has been demonstrated that 
all three are present in the regulatory complex (the presence 
of additional components has not yet been excluded). Since it 
appears that the proteins HAP2 and HAP3 are primarily 
responsible for the site-specific DNA-binding of the complex, 
the requirement for HAP4 for binding suggests that HAP4 
stabilizes the HAP2-HAP3 complex or alters its conformation 
(Olesenet al., 1987; Forsburg and Guarente, 1989). The HAP4 
subunit of the complex would also provide the primary tran- 
scriptional activation domain (Olesen and Guarente, 1990). 
SNF2 ( G A M I ) ,  SNFS, SNF6 
The genes SNF2, SNFS and SNF6 were identified in a 
search for mutants unable to ferment sucrose or raffinose 
(Neigeborn and Carlson, 1984) and their products appear to 
act in a concerted form. The genes were subsequently cloned 
by complementation of the phenotype (Abrams et al., 1986; 
Estruch and Carlson, 1990b). GAMZ was described as a gene 
required for transcription of the STAI gene which encodes an 
extracellular glucoamylase of S .  cerevisiae var. dia.staticus. 
It was then found to be allelic with SNF2 (Yoshimoto and 
Yamashita, 1991) 
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The SNF2 gene encodes a protein of 1703 amino acids 
with 30% charged residues and several short acidic and basic 
regions. Other special characteristics are a glutamine-rich re- 
gion, a stretch rich in glutamine and alanine residues and nine 
tandem repeats of the dipeptide arginine-glycine (Laurent et 
al., 1991 ; Yoshimoto and Yamashita, 1991). Deletion of SNF2 
is not lethal but causes slow growth on glucose; SNF2 is 
required for growth on raffinose, galactose or glycerol 
(Laurent et al., 1991). 
The SNFS gene encodes a protein of 905 amino acids 
with a peculiar composition: of the 270 amino acids between 
positions 31 and 300,46%0 are glutamine; the protein has also 
three regions with high proline content. However, a deletion 
of codons 60-296, which removes 110 glutamine and 28 
proline residues, does not affect the function of SNF.5. Also 
noteworthy is the high charge of the carboxy-terminal 213 
amino acids of the predicted SNF5 protein. There are both a 
very acidic stretch (net charge -17 over 99 residues) and a 
basic one (net charge + 8 over 44 residues) (Laurent et al., 
1990). 
The SNF6 gene encodes another highly charged protein of 
332 amino acids; the central third of the protein has 45% 
charged residues, the number of acidic and basic residues 
being very similar (Estruch and Carlson, 1990b). 
The products of all three genes are localized in the nucleus 
of the yeast cell (Laurent et al., 1991; Yoshimoto and 
Yamashita, 1991; Laurent et al. 1990; Estruch and Carlson, 
1990b). The nuclear targeting signal of SNF2 could be lo- 
calized at the carboxy terminus, between residues 1423 and 
1554 (Laurent et al., 1991). 
The requirement of SNF2, SNFS or SNF6 for high level 
SUC2 expression can be obviated by the spt6 mutation. These 
results suggest a concerted action of the products of the three 
genes. To examine the mode of action of the gene products, 
the lexA operator region was fused to a reporter gene and 
fusions of LexA with SNF2 and SNF5 were constructed. Both 
fusion proteins activated transcription of the reporter gene 
(Laurent et al., 1990; Laurent et al., 1991). The activation by 
the fusion protein LexA-SNF2 is dependent on functional 
SNFS and SNF6 genes, while that by the LexA-SNF5 fusion 
depends on the integrity of SNF2 and SNF6. In this system 
the requirement for SNF2 or SNFS but not that for SNF6 
could be relieved by the spt6 mutation. These results, together 
with the findings that overexpression of SNF2 does not abolish 
the requirement for SNFS and vice versa and that the double 
mutant snf2 snf5 does not grow more slowly than the single 
mutants, suggest that SNF2 and SNFS play similar, but non- 
redundant functions. SNF2 and SNFS could form a complex 
which binds to DNA but there is no evidence for DNA- 
binding activity of these proteins. Therefore, if they bind to 
DNA, they should interact with a factor (or with a family of 
them) which would provide the DNA-binding capacity and 
specificity, while both SNF2 and SNF5 would provide the 
activation domain. SNF6 could affect the SNF2/SNF5 func- 
tion, either by binding to the complex or through a different 
mechanism. In any case SNF6 is not required for the ex- 
pression or nuclear localization of SNF2 or SNFS (Laurent 
et al., 1991). 
M S N l  
Suppression of the temperature-sensitive phenotype of 
some cat1 mutants by genes expressed from multicopy 
plasmids allowed the identification of M S N l .  Gene M S N l  
encodes a protein of 382 amino acids rich in serine and thre- 
onine (17%) and asparagine and glutamine (18%). In ad- 
dition, the carboxy-terminal region is highly basic (net charge 
+ 13 over 78 residues) and appears to be required for function. 
A LexA-MSN1 fusion protein is able to activate transcription 
of a gene carrying the LexA operator and an MSNl-b- 
galactosidase fusion protein is localized in the nucleus; how- 
ever, the MSNl protein synthesized in vitro exhibits only weak, 
non-specific DNA-binding activity. Therefore, if MSN 1 func- 
tions as an activator of transcription, it should do so in cooper- 
ation with other proteins. A strain carrying a disrupted MSNI  
gene has 3 - 4-fold reduced levels of derepressed invertase. The 
small effect of the MSNI disruption on invertase derepression 
could suggest that other genes function redundantly with 
MSNl  to affect SUC2 expression and in fact MSNI probes 
detect multiple RNAs which could encode partially homolo- 
gous, functionally redundant proteins (Estruch and Carlson, 
1990a). 
Intermediary elements necessary for repression 
In the presence of non-metabolizable sugars which act as 
gratuitous repressors, wild-type yeast does not utilize carbon 
sources whose utilization requires enzymes sensitive to 
catabolite repression. Therefore a standard procedure to un- 
cover mutations which abolish catabolite repression has been 
to look for mutants able to grow on media containing glucos- 
amine or 2-deoxyglucose together with a carbon source like 
galactose, maltose, raffinose or lactate. In this way many of 
the following elements were identified. 
HXK2 ( H E X I ,  GLRI)  
hex1 mutants were isolated by Zimmermann and Scheel 
(1977) and Entian and Zimmermann (1980) and glrl  mutants 
by Michels and Romanowski (1980). They were later found 
to be allelic to the gene HXK2 encoding the hexokinase 
isoenzyme P-I1 (Lobo and Maitra, 1977). This raised the ques- 
tion whether the role of the product of gene HXK2 in the 
catabolite repression of certain genes depends on its 
hexokinase activity or is due to a separate regulatory domain. 
A first set of experiments suggested that there were two do- 
mains in hexokinase I1 and that hexokinase I, the product of 
HXKI,  could not fulfil the same role as hexokinase I1 (Entian 
and Frolich, 1984; Entianet al., 1985). However, recent results 
indicate a strong correlation between catalytic activity of both 
hexokinases I and I1 and their capacity to mediate catabolite 
repression (Ma et al., 1989a, b;  Rose et al., 1991). The exact 
mode of action of HXK2 is still far from understood. The 
protein appears to possess protein kinase activity (Fernandez 
et al., 1988; Herrero et al., 1989) and this activity could be 
related with its regulatory function. Since glucose itself is a 
substrate for hexokinase, it seems plausible that HXK2 be 
implicated in the production or transduction of the signal for 
glucose presence. Interestingly glucokinase, another enzyme 
able to phosphorylate glucose in yeast, does not seem to be 
able to play the same role as the hexokinases (Rose et al., 
1991). Another intriguing observation is the in vivo phos- 
phorylation of both hexokinases, which increases in 
derepressing conditions (Vojtek and Fraenkel, 1990). This 
could suggest that the state of phosphorylation of hexokinase 
I1 affects glucose repression. 
H E X 2  (REGI)  
hex2 mutations were identified in a search for mutants with 
non-repressible invertase (Entian and Zimmermann, 1980). It 
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was found later (Niederacher and Entian, 1987) that hex2 is 
allelic to regl, a mutation isolated as conferring resistance to 
catabolite repression of galactokinase synthesis (Matsumoto 
et al., 1983b). HEX2 has been cloned by selecting for growth 
on maltose (Niederacher and Entian, 1987) since hex2 mutants 
are unable to grow on maltose, although the reason for this 
phenotype is still unclear (Entian and Loureiro-Dias, 1990). 
HEX2 encodes a protein of 1026 amino acids with no dis- 
tinguishing features except a region with five consecutive ser- 
ine residues in the middle of an acidic stretch and a further 
acidic region. There are strong indications for a nuclear local- 
ization of the HEX2 protein (Niederacher and Entian, 1991). 
CAT 80 (GRRl  ) 
cat80 mutants were isolated by Entian and Zimmermann 
(1980) and grrl mutants by Bailey and Woodward (1984) 
and by Flick and Johnston (1991); they appear to be allelic 
(Niederacher D., cited in Schiiller and Entian 1991). CAT80 
codes for a large protein of 1151 amino acids which presents 
as a striking feature 12 tandem repeats of a motif of 26 amino 
acids rich in leucine and other hydrophobic residues. The 
protein has a high content of asparagine and leucine residues 
(11% and 12%, respectively) and contains 23 potential sites 
for N-linked glycosylation (Asn-Xaa-Ser/Thr). At both the 
amino and carboxy ends are stretches rich in asparagine and 
glutamine. The CAT80 protein appears to be part of a large 
complex localized in the cytoplasm that sediments at 10000 x g 
and is only solubilized by urea. Although its mode of action 
is unknown, it has been suggested that CAT80 is required for 
the generation or transduction of the intracellular signal that 
causes glucose repression (Flick and Johnston, 1991). 
MIG I 
Screening a yeast library for genes which, in multicopy, 
would turn off the GAL1 promoter under inducing conditions, 
the MIGI gene was isolated (Nehlin and Ronne, 1990). MIGI 
encodes a protein of 504 amino acids with two CyszHisz zinc 
finger motifs in the amino-terminal region. There are also 
several short stretches of glutamine and glutamine alternating 
with asparagine. By DNaseI footprinting, the MIGI protein 
has been found to bind to the promoter of the genes SUC2 
(Nehlin and Ronne, 1990), GALI, GAL4 (Nehlin et al., 1991) 
and FBPI (Mercado et al., 1991; Ronne H., personal com- 
munication). In contrast to the proteins discussed previously, 
it does not require other proteins to bind DNA (Nehlin and 
Ronne, 1990; Nehlin et al., 1991). MIGI appears to act as 
a repressor of transcription in the presence of glucose; if 
overexpressed it can even repress transcription of SUC2 in the 
absence of glucose (Nehlin and Ronne, 1990). 
RGRI 
rgrl mutants were isolated as causing overexpression of a 
reporter gene placed under the control of the SUC2 promoter 
(Sakai et al., 1988). The mutation has pleiotropic effects: 
invertase resistance to catabolite repression, reduction in the 
amount of reserve carbohydrates, defects in sporulation, tem- 
perature sensitivity for growth and abnormal cell morphology 
(Sakai et al., 1988). RGRI encodes a hydrophobic protein 
of 1082 amino acids with six possible membrane-spanning 
domains in its sequence. It is essential for growth, since a 
null rgrl mutation results in a lethal phenotype. It has been 
suggested that the RGRI protein could interact with the RAS- 
CAMP pathway (Sakai et al., 1990). 
TUPI (FLKI ,  UMR7, CYC9, A M M I ,  SLEZ), CYC8 (SSN6) 
Mutations that affect catabolite repression but also present 
diverse pleiotropic effects, including flocculence, have been 
isolated by different groups. The mutations tupl and cyc8 
relieve catabolite repression for a variety of genes. tupl 
(Wickner, 1974) is allelic toflkl (Schamhart et al., 1975; Stark 
et al., 1980), to umr7 (Lemmont, 1977) to cyc9 (Rothstein and 
Sherman, 1980), to amml (Trash-Bingham and Fangman, 
1989) and to $2 (Fujita et al., 1990), while cyc8 (Rothstein 
and Sherman, 1980) is allelic to ssn6 (Carlson et al., 1984) . 
The gene TUPI has been cloned (MacKay, 1983; Fujita 
et al., 1990) and shown to code for a protein of 713 amino 
acids with long stretches of glutamine and threonine (Williams 
and Trumbly, 1990; Fujita et al., 1990). The carboxyl third of 
the predicted TUPl protein contains six repeats of a pattern 
of 43 amino acids. The same pattern of conserved residues is 
seen in the P-subunit of transducin and in the yeast CDC4 
gene product required for progression beyond the GI  phase 
of the cell cycle. This similarity of the TUPl protein to sub- 
units of G proteins suggests that the TUPI repeat domain 
could be involved in protein- protein interactions. The im- 
portance of this region for TUPl function is indicated by the 
fact that removal of the 39 carboxy-terminal residues results 
in a strong mutant phenotype (Williams and Trumbly, 1990). 
The gene CYC8 codes for a protein of 966 amino acids 
with a high proportion of glutamine residues. There are two 
polyglutamine stretches and a domain of alternating gluta- 
mine and alanine residues (Schultz and Carlson, 1987; 
Trumbly, 1988). The polyglutamine tract near the amino ter- 
minus is dispensable, even in the absence of the tracts of 
polyglutamine and poly(g1utamine-alanine) in the middle of 
the protein. A deletion removing a third of the protein at the 
carboxy terminus did not cause a severe mutant phenotype 
(Schultz and Carlson, 1987). The CYC8 protein includes near 
its amino terminus 10 tandem repeats of a 34-amino-acid 
sequence which has been named the tetratricopeptide repeat 
(Sikorski et al., 1990 ). It has been proposed (Hirano et al., 
1990) that the tetratricopeptide units form a novel secondary 
structure, named a ‘snap helix’, which produces a tightly 
packed structure and would allow association with similar 
domains of other proteins. A protein with only three or four 
tetratricopeptide repeats is still functional but larger deletions 
abolish function (Schultz et al., 1990). Although the CYC8 
protein is localized exclusively in the nucleus the protein lacks 
consensus domains for DNA-binding proteins and extensive 
efforts for detecting DNA-binding activity have been unsuc- 
cessful (Schultz et al., 1990). 
The CYC8 and TUPI proteins can associate in a high- 
molecular-mass complex. It is not known how many CYC8 
and TUPI molecules participate in the complex and the pres- 
ence of other components has not been ruled out (Williams et 
al., 1991). In relation to the association of CYC8 and TUP1, 
it should be noted that the TUPl protein lacks the 
tetratricopeptide repeat characteristic of CYC8 ; therefore it 
would be likely that some other protein(s) form a junction 
between TUPI and CYC8. Since overproduction of CYC8 or 
TUPI reduces transcription of the SUC2 gene, even in the 
absence of glucose (Schultz and Carlson, 1987; Williams and 
Trumbly, 1990), it appears that the complex CYCS/TUPl 
plays an inhibitory role on the transcription of SUC2. It 
would not act, however, directly at the DNA level but through 
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Table 4. Catabolite repression mutants not well characterized. 
Type of mutation Name of the Characteristics Reference 
mutation 
Non-derepressible ccr2 non-allelic to cutl or ccr3 Ciriacy 1977 
ccr3 ChrV, linked to trp2 Ciriacy 1977 
ccr4 Chr I, between cys3 and cysl Denis 1984 
CCR80 Ciriacy 1978 
CCR91 
cidl 
cut4 
epistatic over cutl Zimmermann et al. 1977 
Boker-Schmitt et al. 1982 
Neigeborn & Carlson 1987 
Schiiller & Entian 1991 
Non-repressible cut2 
non-allelic with tupl,  cyc8, hxk2, hexl ,  migl 
non-allelic with tupl, cyc8, hxk2, hex2, cut80, cidl 
Table 5. Action range of mutations affecting derepression. Abbreviations: ADH 11, alcohol dehydrogenase 11; FbPase, fructose 1,6-bis- 
phosphatase; +, affects expression of the corresponding gene; -, without effect; -k, partial effect; nt, not tested. 
Mutation Proteins affected 
invertase maltase galactokinase ADH I1 cytochromes FbPase 
cutl + + + + + + 
cut3 + + + nt + + 
hup2, hup3, hap4 - 
ccr2, ccr3, ccr4 nt nt + * + 
nt + + 
snf2, snf5, snf6 + + + nt nt nt 
msnl + nt nt nt nt nt 
- nt 
- 
interaction with some DNA binding protein. The products of 
the SNF2, SNF.5 and SNF6 genes have been suggested as 
possible targets (Williams and Trumbly, 1990). Although 
CYC8 is phosphorylated in vivo (Schultz et al., 1990), the 
significance of this phosphorylation is not clear. 
Other regulatory elements 
Other genes affecting catabolite repression have been de- 
scribed. However, since most of them could be allelic to some 
of the better identified genes, their status is still uncertain. 
These genes and their allelic relations, when known, are listed 
in Table 4. Another set of mutants named lgnl-9 with 
pleiotropic effects has been isolated. These mutants are affect- 
ed in the regulation of repression - derepression of a variety 
of genes encoding enzymes belonging to the tricarboxylic acid 
cycle, the electron transport chain and the gluconeogenic path- 
way (Bisson, 1988). Differences in the background of the 
wild-type strains precluded complementation tests with snf 
mutations. 
Finally, some genes connected with catabolite repression 
appear to be specific for a single gene or set of genes. Examples 
would be GAL82, GAL83 for genes coding for enzymes of the 
galactose pathway (Matsumoto et al., 1981) or ADR6 for the 
ADH2 gene (Taguchi and Young, 1987). ADRl ,  which was 
also considered specific for the ADH2 gene, has recently been 
shown to activate also the transcription of genes encoding 
peroxisomal proteins (Simon et al., 1991). 
Effect of the intermediary elements on the expression 
of different genes 
As indicated in the introduction, there is a large variety of 
genes whose expression is regulated by catabolite repression. 
The different catabolite repression mutants isolated have been 
identified by their action upon one or another of these regu- 
lated genes and their effect on other genes has not been system- 
atically tested. Our knowledge on the role of the intermediary 
elements in catabolite repression therefore remains very frag- 
mentary. It would be useful to test the effect of the different 
mutations in as large a number of systems as possible to 
establish two points: what is the range of action of each 
intermediary element and what are the elements implicated in 
the regulation of a given gene? A problem when approaching 
this goal can be the fact already mentioned that the effects of 
a mutation on a particular system vary depending on the 
genetic background of the yeast strain, e.g. cat1 affects ex- 
pression of SUC2 in certain strains (Neigeborn and Carlson, 
1984) while it has no effect in others (Zimmermann et al., 
1977). Tables 5 and 6 summarize which genes have been re- 
ported to act on different systems and I will discuss in a later 
section how the different intermediary elements could interact 
to regulate specific genes. 
It may be worth pointing out that many of the intermedi- 
ary elements described present either acidic regions or gluta- 
mine-rich stretches and one of them, SNF.5, has three proline- 
rich sequences. Although these types of region have been 
found in protein domains responsible for transcriptional acti- 
vation (Mitchell and Tjian, 1989), it does not necessary follow 
that all the intermediary elements featuring these regions are 
directly implicated in the activation of transcription. It is more 
likely that these particular regions have the more general role 
of participating in protein - protein interactions implicated, 
at different levels, in the control of gene expression. 
CIS-REGULATORY ELEMENTS 
In this section I will review the studies performed on the 
promoters of a variety of genes subject to catabolite repression 
to try to delineate which sequences are important in mediating 
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Table 6. Action range of mutations affecting catabolite repression. Abbreviations as in Table 5.  
Mutation Proteins affected 
invertase galactokinase cytochromes isocitrate lyase FbPase 
tupl + nt + + nt 
cyc8 + + + + nt 
migl + + nt nt 
rgr I + nt nt nt nt 
CCRYl nt nt + nt nt 
cidl + - nt nt nt 
- - hxk2, hex2, cat80 + + & 
- 
CCR80 f nt nt * f 
- cat4 + + + * 
A 
Enzyme activity (%) 
-1900 -900 -650 -223 suc2 No glucose Glucose 
-437 -406 -384 
I I w/  ' c 100 <2 
100 <2 
c--/ - - - - w 200 4 
B 
47 24 
Fig.2. Effect of different fragments of the SUC2 promoter on the 
expression of SUC2 and of a LEU2-lacZ fusion. (A) Deletions were 
performed in the promoter region of the SUC2 gene and invertase 
was measured in yeast cells containing the different constructions. (B) 
Fragments of the SUC2 promoter were fused to a LEU2-lacZ gene 
and /l-galactosidase was measured in yeast cells containing these con- 
structions. The yeasts were grown in the absence or presence of glu- 
cose. Enzyme activity is given as a percentage of the activity shown 
by the constructions with the largest promoter fragment. Adapted 
from Sarokin and Carlson (1984, 1986). For more details see text. 
the effect of glucose. In most cases a similar strategy has been 
utilized, which consists in defining which fragment of the 
promoter region is necessary to direct the regulated transcrip- 
tion of a reporter gene and, in a second phase, in evaluating 
the effect on transcription of a variety of deletions in the 
promoter. 
SVC genes 
There is a family of SUC genes coding for invertase but 
the most thoroughly studied is the gene SUC2. As shown in 
Fig. 2, sequences upstream of -650 and between -403 and 
- 223 are dispensable for the regulated expression of this gene. 
A variety of deletions did not reveal any region which could 
be responsible for direct negative regulation of the SUC2 gene 
in response to glucose (Sarokin and Carlson, 1984). A fusion 
of the - 9001 - 384 region with a LEU2-lucZ gene increased 
lucZ expression about 25-fold in the absence of glucose but 
had no effect in its presence. Expression of this fusion was 
regulated, like that of a normal SUC2 gene, by the truns- 
acting genes CATI, SNF.5 and CYC8 (Sarokin and Carlson, 
1985a). A sequence of 32 bp situated between -437 and 
- 406 activates slightly lucZ expression but the activatory 
effect is increased when several copies of the 32-bp sequence 
are placed in tandem. In these constructions expression is little 
affected by glucose or by the trans-acting genes mentioned 
(Sarokin and Carlson, 1986). 
Within the 32-bp sequence, a 7-bp element has been identi- 
fied which is repeated with small variations at other places in 
the upstream-activating region of SUC2. Similar sites are also 
found in the SUC7 promoter (Sarokin and Carlson, 1985b) 
and in the promoters of SUC1, SUC3, SUC4 and SUC.5 
(Hohmann and Gozalbo, 1988). The consensus sequence of 
these sites is (A/C)(A/G) GAAAT. The hypothesis that these 
elements play a regulatory role (Sarokin and Carlson, 1986) 
is strengthened by the fact that deletions that affect the 7-bp 
elements also affect SUC2 expression (Sarokin and Carlson, 
1984). Moreover a deletion mutant A-456/-223 which had lost 
two copies of the 7-bp element showed a tenfold decrease in 
invertase expression. Pseudorevertants of this mutant were 
obtained and several of them had been mutated in the 7-bp 
element around position -476. This particular element did 
not match exactly the consensus sequence since it had only 
two adjacent adenine residues. The three different mutations 
in the pseudorevertants produced sequences with three con- 
secutive adenine residues which were more closely related with 
the consensus sequence. In the three cases invertase expression 
was greatly increased and the increase was most marked (36- 
fold) for a mutation which gave a perfect match (Sarokin and 
Carlson 1986). These results support the significance of the 
7-bp repeated elements for SUC2 transcription. 
In the SUC2 promoter two sequences have been identified 
able to bind the product of the regulatory gene MZGl (Nehlin 
and Ronne, 1990). The removal of one of the binding se- 
quences has no effect on glucose repression (Sarokin and 
Carlson, 1984) but the removal of the other has not been 
attempted. That the binding of MIGl to at least one of the 
sites in the SUC2 promoter mediates repression by glucose is 
suggested by the finding that a migl null mutation makes 
the synthesis of invertase much less sensitive to catabolite 
repression (Nehlin and Ronne, 1990). The observation that 
the 32-bp sequence from the SUC2 promoter, which is able to 
activate transcription even in the presence of glucose, does 
not contain a complete MIG1-binding sequence also supports 
a regulatory role for this sequence. 
MAL genes 
A family of at least five MAL loci exists in Succhuromyces 
species. Each of the loci comprises two structural genes, which 
encode maltose permease and maltase respectively, and a regu- 
latory gene encoding an activator of transcription. The MAL6 
locus has been studied most thoroughly and upstream and 
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internal deletions of the MAL6S gene, coding for maltase, 
have been generated (Hong and Marmur, 1987). The analysis 
of these mutations indicates that a T-rich region at position 
- 253 to - 237 relative to the MAL6S ATG initiation codon 
may be involved in catabolite repression since removal of this 
region increases activity under repressing conditions up to 
fivefold. An examination of the MAL6S promoter sequence 
(Hong and Marmur, 1986) shows that there are at least two 
sites with a sequence similar to the consensus sequence for 
binding the regulatory protein MIGl (Griggs and Johnston, 
1991; Nehlin et al., 1991). As in the case of the SUC2 gene 
removal of one of these sequences has no effect on glucose 
repression (Hong and Marmur, 1987) and removal of the other 
one has not been performed. 
GAL genes 
Two different approaches have been used to look for se- 
quences in the GAL genes which could be responsible for 
glucose repression. In one approach gene fusions containing 
whole promoters were constructed, most often GALI-lucZ 
or GALIO-lacZ, and the effect of progressive and internal 
deletions upon glucose repression of the transcription was 
tested. In the other approach different fragments of a GAL 
gene promoter were ligated to a hybrid gene which had a 
functional upstream activating sequence insensitive to glucose. 
The first approach showed that the deletion of a region of 
160 bp from the GAL1 promoter lowered glucose repression 
by a factor of 15 - 30. This deletion, however, also allowed a 
significant constitutive transcription (that is, independent of 
induction by galactose) and it was not clear whether these 
effects result from a decrease in the distance between an up- 
stream activating sequence UASG and the TATA box or from 
the removal of specific sequences able to bind negative regula- 
tory proteins (West et al., 1984). The second approach allowed 
the identification of specific sequences able to mediate nega- 
tive control by glucose. The degree of repression conferred by 
these sequences was relatively low, from 5-fold (Struhl, 1985) 
to 30-fold (Flick and Johnston, 1990). Although one of the 
negatively &-acting sites, URS-A (Flick and Johnston, 1990), 
binds the regulatory protein MIGl (Nehlin et al., 1991), the 
role of these sites in mediating catabolite repression in the 
intact genes is probably marginal (see next section). 
Genes coding for elements of the respiratory chain 
To map the site(s) responsible for catabolite repression in 
the gene CYCI, encoding the iso-1-cytochrome c, CYCI-lucZ 
fusions have been constructed. A truncated promoter ex- 
tending from position -229 to - 178 was sufficient to direct 
transcription repressed by glucose (Guarente et al., 1984). 
The corresponding upstream activating sequence was named 
UAS2. Activation by this sequence depends on the presence 
of the trans-acting genes HAP2, HAP3 and HAP4 (see earlier 
section). In a gel retardation assay, the fragment -263 to 
- 173 of the CYCI promoter, which contains the UAS2 se- 
quence, formed three distinct protein-DNA complexes 
(Olesen et al., 1987). One of them was found only in dere- 
pressed conditions and in this complex the protein made con- 
tacts within a consensus TN(A/G)TTGGT sequence. This 
sequence is found in different promoters (CYCI, HEMI,  
COX4 etc.) controlled by HAP2, HAP3 and HAP4 (Maarse 
et al., 1988; Calder and McEwen, 1990). A mutation in the 
wild-type CYCI promoter which changed the third base in the 
regulatory element from G to A increased transcription; the 
mutated sequence was called UP1 element (Olesen et al., 1987). 
The UAS2 site from CYCI has been further analyzed in con- 
structions with CYC1-lad fusions activated by the wild-type 
or the UP1 form of UAS2 (Forsburg and Guarente, 1988). 
Sequences upstream of - 230 appear dispensable. Although 
3’ deletions up to -200 maintain still a significant expres- 
sion regulated by glucose, sequences between - 190 and 
-178 are necessary for maximal expression. A short dyad 
GCTCN,GAGC between positions - 227 and - 21 3 could be 
important for transcription since a 3’ deletion destroying the 
consensus and all downstream sequences but leaving the dyad 
intact has a weak activity induced by lactate. Therefore within 
UAS2 two regions have been defined: region 1 from -229 
to - 200, which mediates catabolite repression and which 
includes the dyad and the consensus binding site for HAP2/ 
HAP3/HAP4, and region 2 from - 190 to - 178 which in- 
creases the activating effect of region 1. 
ADH2 
Transcription of the ADH2 gene, which encodes the 
alcohol dehydrogenase I1 used for catabolizing ethanol, is 
repressed in cells grown on glucose (Denis et al., 1981). Initial 
experiments suggested that it was possible to perform a de- 
letion in the promoter in such a way that catabolite repression 
would be eliminated (Beier and Young, 1982); however, 
further studies have shown that the rate of transcription 
changed markedly when different regions of the promoter 
were removed but that glucose repression was maintained in 
all cases (Beier et al., 1985; Yu et al., 1989). 
FBPl 
The gene FBPl encoding fructose 1,6-bisphosphatase is 
also controlled by catabolite repression. Deletion analysis al- 
lowed the identification of a region of the promoter which 
could be involved in the repression by glucose. When the 
region from - 480 to - 170 was deleted, the repression factor 
decreased from 140-fold to about 2-fold while the maximal 
level of expression was reduced by less than 4-fold (Mercado 
et al., 1991). In the regulatory region three sites potentially 
able to bind the regulatory protein MIGl have been identified; 
in foot-printing experiments two of them have been found to 
bind nuclear proteins (Mercado et al., 1991). 
INTEGRATION OF THE DIFFERENT ELEMENTS 
The final goal in the study of catabolite repression is to 
understand how the different elements of the system interact 
to produce the changes in transcription observed in the pres- 
ence and absence of glucose. A point that has become clear 
as our knowledge has increased is that the mechanisms of 
regulation are not identical for different genes. Therefore we 
will consider the mechanisms of regulation of a small number 
of genes for which substantial information is available. 
Regulation of the SUC2 gene 
The gene SUC2 coding for invertase has been most 
thoroughly studied. Since it does not require induction by a 
carbon source, its regulation appears less complex than that 
of other genes; nevertheless, a bewildering number of trans- 
acting factors are involved in SUC2 control. We have already 
described the products of the genes CATI, CAT3, SNF2, 
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Table 7. Epistatic relations between different mutations affecting SUC2 transcription. Invertase activity is cxpressed in a semiquantitative 
manner, - indicating no activity and + + + + maximal activity. 
Relevant genotype Invertase activity 
repression derepression 
Reference 
Wild type 
snf2/snfS/snf6 
tupl /eye8 
snf2cyc8/snf5cyc8/~~nf6cyc8 
migl 
catllcat3 
cat1 tupllcatlcyc8 
catlniigl 
hxk2/he.u2lcat80 
catl hxk2/catl hex2 
spt6 
sriflsp t6lsn fSspt6/sn f6sp t6 
msn I 
catl + multicopy MSNl 
cyrl 
cyrl cyc8 
- +++  
k - 
+ + + +  + + + +  
+ + +  
+ + + + +  
++++  + + + +  
* - 
+++  +++  
- - 
+++  
+++  
+ +  
+ +  
+ + + +  
Neigeborn & Carlson 1984 
Trumbly (1986) 
Neigeborn & Carlson 1984 
Estruch & Carlson 1990b 
M. Carlson (pers. commun.) 
Neigeborn & Carlson 1984 
Neigeborn & Carlson 1984, 1987 
M. Carlson (pers. commun.) 
Entian & Zimmermann 1980 
Neigeborn & Carlson 1987 
Neigeborn et al. 1987 
Neigeborn et al. 1986 
Estruch & Carlson 1990a 
Estruch & Carlson 1990a 
Schultz & Carlson 1987 
Schultz & Carlson 1987 
SNFS, SNF6 and MSNl which are required for maximal 
derepression to take place and the products of the genes 
HXK2, HEX2, CAT80, TUPl,  CYC8, MIGl ,  RGRl, which 
are necessary for repression to occur. Further genes like 
CCR80, CIDl and CAT4 could also play a role (see Table 4). 
To establish the level at which the different genes act, epistatic 
relationships, that is the effects of double mutations on SUC2 
transcription, have been studied with the results shown in 
Table 7. From these data and from the biochemical features 
of the products of trans-acting genes (see earlier section) the 
following conclusions can be deduced. 
a) The complex SNF2/SNFS/(SNF6) appears to play a 
direct role in the activation of SUC2 transcription. The fact 
that there is no evidence for the binding of SNF2 or SNFS to 
the DNA suggests that the complex could act as a transcrip- 
tional adaptor (Berger et al., 2990) or a mediator (Flanagan 
et al., 1991) between the RNA polymerase I1 complex and a 
still unidentified, DNA-binding, activating factor X. 
b) SPT6, an essential gene which appears to affect 
chromatin structure (Swanson et al., 1990), would maintain 
the DNA in a tight conformation which requires activators 
for transcription to take place. In spt6 strains SUC2 can be 
expressed in the absence of SNF2, SNFS or SNF6 or when 
large regions of the SUC2 promoter have been removed 
(Neigeborn et al., 1987). In this later case the expression is 
only slightly affected by glucose (2  - 4-fold) unless there is an 
MIG1-binding region in the promoter (in these conditions 
glucose repressed about 25-fold). This, in turn, suggests that 
the negatively acting DNA-binding protein MIGl is able to 
respond to the presence of glucose. 
c) M S N l ,  which is not absolutely required for SUC2 tran- 
scription, would only increase the rate of SUC2 expression. It 
would operate only in the absence of glucose, since MSNl in 
multicopy can bypass the requirement for CATI for SUC2 
expression but does not overcome catabolite repression. 
d) Next in the hierarchy would be the complex CYC8/ 
TUP1, since cyc8 is only partially epistatic over snf2, 4 5 ,  
snf6 but cyc8 and tupl  are epistatic over catl. CYCSiTUPl 
would inhibit SUC2 transcription since in cyc8 or tupl mu- 
tants SUC2 is transcribed at a high rate independently of the 
carbon source present. 
e) CATl and CAT3 would exert their action by modifi- 
cation of CYCS/TUPl. 
f ,  The products of the genes HXK2, HEX2 and CAT80 
would act further upstream, probably signaling the presence 
of glucose to CATl and CAT3. 
This would result in the model shown in Fig. 3. Glucose, 
in the presence of the proteins HXK2, HEX2 and CAT80, 
displaces the equilibrium between active and inactive CATl/ 
CAT3 complexes towards the inactive form. In the absence of 
glucose, CATl/CAT3 is in an active form and inactivates 
the complex CYCS/TUPl, perhaps through phosphorylation. 
Inactivation is not complete, however, since expression of 
SUC2 is higher in cyc8 or tupl mutants than in a derepressed 
wild-type strain. A dominant mutant of CATI, CATI-2d 
(Zimmermann et al., 1977), which causes a less tight re- 
pression, would code for a protein permanently active. 
The rate of SUC2 transcription depends on a balance 
between activation by MSNl and X (together with SNF2, 
SNFS, SNF6) and inhibition by MIG1. The complex CYC8/ 
TUPl could both facilitate binding and/or increase activity of 
the inhibitory factor MIGl and interfere with the binding 
and/or activity of the activating factor X. 
One possible mode of action for glucose would be to affect 
the transcription of some of the regulatory genes; however, 
the results available indicate that the steady-state levels of 
the products of CATl (Celenza and Carlson, 1984), CAT3 
(Schuller and Entian, 1987), SNF2, SNFS (Abrams et al., 
1986), SNF6 (Estruch and Carlson, 1990b), HXK2 (Gancedo 
et al., 1977), HEX2 (Niederacher and Entian, 1991), CAT80 
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Fig.3. A simplified model for the regulated expression of the SUC2 
gene. In the absence of glucose, SUC2 is transcribed due to the 
activating effects of the proteins MSNl and X and to the action of 
the mediator complex SNF2/SNFS/(SNF6). In the presence of glu- 
cose, the proteins HXK2, HEX2 and CAT80 favour the formation of 
thc inactive form of the complex CATl/CAT3. When this complex is 
inactive, the CYC8/TUPl complex is active and it facilitates the 
binding and/or activity of the inhibitory factor MIG1. At the same 
timc it inhibits the binding and/or activity of the activator X. MSNl 
is down-regulated by glucose independently of CATI. These different 
controls result in a decreased transcription of SUC2 in the presence 
of glucose. For more details and the role of SPT6 see text. 
(Flick and Johnston, 1991), CYC8 (Schultz and Carlson, 
1987), TUPI (Williams et al., 1991) and MZGI (Nehlin and 
Ronne, 1990) are independent of the presence or absence of 
glucose in the growth medium. Therefore glucose is more 
likely to act by modifying the activity of one or more of the 
regulatory gene products by a mechanism hitherto undefined. 
In any case, glucose does not operate exclusively through 
CAT1 and CYC8, since mutants like cut1 with multicopy 
MSNl or snf2cyc8 and cyrlcyc8 can still be repressed by 
glucose, at least partially (Table 7). 
The model presented in Fig. 3 is a simplification since 
regulatory proteins with an undefined position in the control 
hierarchy (like RGRl and probably others) have been omitted 
and pieces of the puzzle may still be missing. For instance, the 
role of CCR4, an activating factor negatively regulated by 
SPT6 (Denis and Malvar, 1990), in SUC2 transcription has 
not been examined. That CAMP plays some role in the re- 
pression of SUC2 can be deduced from the fact that cyc8 
partially suppresses a cyrl mutation and from the recent ob- 
servation that overexpression of the CDC25 gene suppresses 
repression of invertase by glucose (Van Aelst et al., 1991). 
CDC25 is involved in the activation of adenylate cyclase by 
the RASl and RAS2 proteins but it is not yet clear how to 
integrate the above findings in the model for SUC2 regulation. 
Still additional types of regulatory mutants have been 
described. Mutation snf3 was isolated in a screen for sucrose 
non-fermenting mutants (Neigeborn and Carlson, 1984) but 
later SNF3 was shown to code for a glucose transporter which 
does not affect SUC2 expression (Neigeborn et al., 1986; 
Celenza et al., 1988). Recently a new mutation, ccsl, linked 
to SNF3 has been identified. Although ccsl mutants express 
invertase normally, ccslsnf3 double mutants express invertase 
constitutively at a level intermediate between those of the 
repressed and derepressed wild-type cells (Marshall-Carlson 
et al., 1990). It has been suggested that CCSI could encode a 
second glucose transporter or a regulator of a glucose trans- 
porter. 
Regulation of the GAL-MEL-LAC genes 
In S. cerevisiue the genes required for the utilization of 
galactose and melibiose (GALI,  GAL2, GAL7, GALIO, 
MELI)  are induced by galactose and repressed by glucose 
(Adams, 1972; for reviews see Oshima, 1982; Johnston, 1987). 
In Kluyveromyces luctis the genes required for the utilization 
of galactose and lactose (GALI,  GAL7, GALIO, LAC4, 
LACI2) are also induced by galactose (Riley and Dickson, 
1984) but the repressing effect of glucose is not very pro- 
nounced and varies between different isolates (Breunig, 1989). 
Although the mode of action of glucose has not yet been 
elucidated, much information has accumulated in the last few 
years about the elements involved in the regulatory circuits 
governing catabolite repression of these genes in S. cerevisiue. 
Transcription of the GALIMEL genes requires the GAL4 
gene (Douglas and Hawthorne, 1966; Hopper et al., 1978; 
Johnston and Hopper, 1982; Laughon and Gesteland, 1982; 
Hashimoto et al., 1983), which encodes a positive control 
protein able to bind to a number of related 17-bp, dyad- 
symmetric sequences which are found in 1-4 copies in the 
promoters of the different genes (Giniger et al., 1985). A 
negative regulatory protein GAL80 can interact with the 
GAL4 protein (Douglas and Hawthorne, 1966; Nogi et al., 
1984; Yocum and Johnston, 1984), in such a way that the 
complex GALCGAL80, although still able to bind at the 
specific DNA sites in the promoter, can no longer activate 
transcription. Since gal80 mutants do not require galactose 
for expression of the GAL genes, it has been concluded that 
galactose acts as an inducer of transcription by counteracting 
the inhibitory effect of GAL80. The mechanism of action of 
the galactose is not clear but it requires the product of the 
gene GAL3, at least for rapid induction (Torchia and Hopper, 
1986). Since GAL3 encodes a protein very similar to 
galactokinase (Bajwa et al., 1988) and a gal3 mutation can be 
suppressed by the GALl genes from S. cerevisiue or from K .  
luctis (Meyer et al., 1991), the role of GAL3 could be to 
catalyze the synthesis of an inducer from galactose. The in- 
ducer, however, would not be Gal-1-P itself since 
galactokinase from E. coli, which is catalytically active in 
yeast, cannot restore normal induction in a gal3 mutant (Bhat 
et al. 1990). It has been suggested that the inducer would bind 
to GAL80 but that has not yet been proven. 
As shown in schematic form in Fig. 4, glucose could block 
transcription either by facilitating the binding to the promoter 
of negative regulatory proteins or by interfering with the acti- 
vation by GAL4. This interference could take place at differ- 
ent levels: glucose could affect the synthesis of GAL4, its 
binding to DNA and the activation of transcription or it could 
antagonize the action of galactose. Strains lacking the protein 
GAL80 no longer require galactose as inducer, although they 
are still dependent on GAL4 for activating transcription. In 
such strains repression of GALl by 2% glucose varies from 
15-fold to 170-fold (Nehlin et al., 1991; Torchia et al., 1984; 
Griggs and Johnston, 1991) in comparison with the 80 - 600- 
fold repression observed in wild-type strains grown in the 
presence of a mixture of glucose and galactose (Nehlin et al., 
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Fig. 4. Possible modes of action of glucose to repress expression of the 
GA L-MEL genes. 
1991 ; Finley et al., 1990). Thus it is clear that glucose interferes 
with galactose induction, a possible mechanism being inducer 
exclusion and another inhibition of the formation of the in- 
ternal inducer by GAL3 (see Johnston, 1987, for a more 
thorough discussion). In addition, glucose has also a very 
marked effect in gal80 mutants where galactose induction is 
not required. 
Ultraviolet footprinting in vivo has been used to study 
DNA- protein interactions in the GALl  - GAL10 upstream 
activating sequences (Selleck and Majors, 1987). It has been 
observed that GALCdependent photofootprints are lost 
under conditions of catdbolite repression and that no footprint 
patterns characteristic of catabolite-repressed cells could be 
identified. These results suggest that glucose acts by interfering 
with GAL4 activation rather than by facilitating the binding 
of a negative regulatory protein to the promoter. Very recent 
results indicate that the effect of glucose is mainly mediated 
through the control of GAL4 synthesis, since in a gal80 strain 
which expresses GAL4 constitutively, catabolite repression 
decreases to 4-fold as compared with 170-fold (Griggs and 
Johnston, 1991). It has also been reported that in a GAL80 
background overexpression of GAL4 abolishes glucose re- 
pression, although a small degree (5-fold) of induction by 
galactose is maintained (Martegani et al., 1990). 
Regarding the control of GAL4 transcription itself by glu- 
cose, it has been shown that glucose causes a modest re- 
pression (4 - 7-fold) of the corresponding gene and that this 
repression is mediated by promoter sequences which bind the 
regulatory protein MIGl (Griggs and Johnston, 1991 ; Nehlin 
et al., 1991). The relatively small decrease in GAL4 concen- 
tration caused by glucose seems largely responsible for the 
changes in GALl transcription (Griggs and Johnston, 1991). 
In the double mutant gal80migl repression of GALl  by glu- 
cose is reduced to a mere 2-fold (Nehlin et al., 1991) indicating 
that the residual level of repression due to the interaction 
of negative regulatory proteins (other than MIG1) with the 
promoter of GALI is very low. It should be noted that MIGl 
is able to bind to the promoter of GALI (Nehlin et al., 1991) 
but the low level of repression in a gal80 strain with constitu- 
tive GAL4 (see above) suggests that the main role of MIGl is 
at the level of GAL4 transcription and that there are no other 
significant negative regulators of the GALl  promoter. 
This is somewhat in contrast with results obtained with an 
element of the GALl promoter which has been called URSG 
and which conferred repression by glucose (independent of 
GAL4) to a hybrid promoter (Flick and Johnston, 1990). It is 
possible that in the intact GALl  promoter the effect of this 
negative element is overriden by activation driven by GAL4. 
In fact the regulation of yeast GAL genes seems to depend on a 
balance between the function of positive and negative control 
elements (West et al., 1987; Finley et al., 1990). In any case, 
the control of the GAL genes is exceedingly complex since a 
whole series of trans-acting genes is also involved in glucose 
repression. We already cited the MIGl gene, whose role in 
regulating GAL4 expression appears well established, but at 
least six other genes have been identified which are required 
for repression of the GAL genes. Mutations in any of the genes 
HXK2 (Zimmermann and Scheel, 1977; Entian, 1980; Ma and 
Botstein, 1986), HEX2 (Matsumoto et al., 1983 b; Neigeborn 
and Carlson, 1987), GAL82, GAL83 (Matsumoto et al., 1981, 
1983 b, GRRl  (Bailey and Woodward, 1984) or CYC8 (Schultz 
and Carlson, 1987) causes a decrease in glucose repression. 
However the mode of action of these genes is unknown. It has 
recently been reported that there are different forms of the 
GAL4 protein and it has been proposed that changes in its 
phosphorylation state could modulate its activity (Mylin et 
al., 1989). A possibility would be that these changes are me- 
diated by the products of the genes GAL82 and GAL83 which 
appear specific to galactose metabolism and that catabolite 
repression in turn depends on modifications of the GAL4 
protein. Another role for the products of some of the trans- 
acting genes could be to participate in the formation of the 
'signal' produced by glucose. In relation to this signal, interest- 
ing observations have been made (Torchia et al., 1984): the 
system is not saturated at 2% glucose, in a gal80 mutant the 
residual expression of GALl  observed at 2% glucose disap- 
pears at 10% glucose; in addition, in agal80 mutant, galactose 
can 'self-catabolite repress' the expression of the galactose - 
melibiose pathway genes by a factor of 2. We are still too 
ignorant to interpret these properties of the system but they 
should be taken into account to propose a sensible model for 
the mode of action of glucose. 
As a final point it should be indicated that expression of 
the GAL genes, as occurs with other genes subject to catabolite 
repression, is dependent on the products of the genes CATI, 
CAT3, SNF2, SNF5, SNF6 (Neigeborn and Carlson, 1984). 
The mode of action of the corresponding proteins has not yet 
been elucidated, but a model similar to that proposed for 
SUC2 (Fig. 3) could be considered for the regulation of GAL4 
transcription. 
Regulation of the ADH2 gene 
Transcription of the ADH2 gene is activated several hun- 
dredfold in glucose-free medium (Ciriacy, 1975; Denis et al., 
1981). Full derepression of the gene requires the product of 
ADRI (Ciriacy, 1975; Denis et al., 1981; Denis and Young, 
1983) and a number of other proteins such as the products of 
CATI (CCRl ) ,  CCR2, CCR3 (Ciriacy, 1977), CCR4 (Denis, 
1984) and ADR6 (Taguchi and Young, 1987). ADH2 ex- 
pression partially escapes glucose repression in some ADRI 
mutants like ADRl-5' (Ciriacy, 1979) and in crel and cre2 
mutants (Denis, 1984). 
Two different pathways appear to control the expression 
of the ADH2 gene. One of them is dependent on the transcrip- 
tional activator ADRI which binds to a 22-bp inverted repeat 
upstream of the TATA element (Shuster et al., 1986). The 
other one depends on CCR4 and does not require sequences 
upstream of the TATA element for activating transcription 
(Denis and Malvar, 1990). Both pathways are subject to re- 
pression by glucose (Denis, 1984; Blumberg et al., 1988) but 
the mode of action of glucose on the CCR4 pathway is un- 
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known. Apparently the products of the genes CREI and CRE2 
(allelic to SPT6 and SPTIO; Denis and Malvar, 1990) act as 
negative effectors in this pathway. With regard to the ADRl 
pathway, it has been observed that ADRl mRNA levels are 
not repressed by glucose and that the ADRI5'mutation which 
increases AD H2 expression 60-fold during glucose repression 
involves the modification of a sequence of the ADRl protein 
which is usually recognized by CAMP-dependent protein 
kinases (Denis and Gallo, 1986). The fact that ADRl is phos- 
phorylated in vitro by a CAMP-dependent protein kinase, that 
increased kinase activity in vivo inhibits ADH2 expression and 
that the degree of inhibition depends on the ADRl allele 
present, support the idea that glucose repression of ADH2 is 
mediated, at least in part, by CAMP-dependent phosphoryla- 
tion of ADRl (Cherry et al., 1989). Phosphorylation of ADRl 
has no effect on its specific binding to DNA; therefore it has 
been suggested that phosphorylation prevents the interaction 
of ADRI with other transcription factors or with RNA poly- 
merase I1 itself (Taylor and Young, 1990). The activation of 
ADRl during derepression could be mediated by a protein 
phosphatase which, in turn, could be regulated by the protein 
kinase CATl which has been shown to be necessary for ADRI 
to be operative (Denis and Gallo, 1986). If ADRl is overpro- 
duced, ADH2 can be expressed in the presence of glucose at 
high levels and this expression is not dependent on the CAT1 
gene (Denis, 1987). A possible interpretation of these results 
is that the system which phosphorylates ADRI in vivo is 
saturated at high concentrations of ADRI and that in these 
conditions a proportion of the transcription factor remains in 
the unphosphorylated, active form independent of the activity 
of CATl. 
The role of ADR6 in any of the circuits is unknown, 
although the corresponding gene has been shown to encode a 
protein with a potential Zn finger of the Cys, type near its 
carboxy terminus. This fact, together with the nuclear location 
of an ADR6-P-galactosidase fusion protein, suggest that 
ADR6 is a direct activator of ADH2 transcription (O'Hara et 
al., 1988). ADR6 appears to be relatively specific for ADH2 
since other enzymes repressed by glucose, like isocitrate lyase 
and malate dehydrogenase, are derepressed normally in an 
adr6 mutant (Taguchi and Young, 1987). 
Regulation of the CYCl gene 
Transcription of CYCI is regulated negatively by glucose 
and positively by heme. In a heme-sufficient medium tran- 
scription is repressed by glucose about fivefold (Zitomer et 
al., 1979). Repression by glucose is relieved in mutants cyc8 
and tupl (cyc9) (Rothstein and Sherman, 1980) as well as in 
hex2 mutants (Borralho et al., 1989). 
Using a CYCI-lucZ fusion gene (Guarente and Ptashne, 
1981) it has been established that the complex HAP2/HAP3/ 
HAP4 is necessary for derepression (Forsburg and Guarente, 
1989). While HAP2 and HAP3 are synthesized constitutively 
(Pinkham and Guarente, 1985; Hahn et al., 1988) HAP4 tran- 
script levels are elevated 4 - 5-fold in the absence of glucose 
(Forsburg and Guarente, 1989). HAP4 could therefore me- 
diate the repression by glucose. It has also been observed that 
the leader of HAP4 mRNA includes two upstream ATGs 
which could confer translational control to HAP4 (Forsburg 
and Guarente, 1989) as occurs with GCN4 (Thireos et al., 
1984; Hinnebusch, 1984). HAP4 transcription could be con- 
trolled by a system similar to that operating on SUC2 since 
transcription of CYCl is regulated, directly or indirectly by 
CYC8, TUPl  (Rothstein and Sherman, 2980), HEX2 
(Borralho et al., 1989) and CAT1 (Wright and Poyton, 1990). 
In addition, the HAP4 promoter contains a sequence 
(Forsburg and Guarente, 1989) corresponding to the consen- 
sus binding site for the negative regulator MIGl (Griggs and 
Johnston, 1991); however, the effect of the migl mutation on 
CYCl expression has not yet been tested. 
It should be indicated that the influence of glucose on 
the transcription of the fusion gene is stronger than that on 
transcription of the CYCl gene and that the effect of most 
mutations affecting the fusion gene has not been cross-tested 
on the expression of CYCI itself. It has been reported that 
hap2 or hap3 mutants had cytochrome concentrations up to 
50% of that of a wild-type strain (Mattoon et al., 1990) but 
it is not clear whether the measurements were made in re- 
pressed or derepressed conditions. These results show, in any 
case, that the complex HAP2/HAP3/HAP4 is not required for 
basal transcription. 
Less well-known systems 
It is not the purpose of this review to list every gene which 
has been shown to be subject to catabolite repression in yeast. 
However, a sampling of a number of systems would be useful 
to show the great diversity of genes controlled by glucose and 
the different ways in which they appear to be regulated. 
NAD-dependent glutamate dehydrogenase 
The NAD-dependent glutamate dehydrogenase from S. 
cerevisiae encoded by the GDH2 gene is an anabolic enzyme 
used to generate ammonia from glutamate and regulated by 
the nitrogen source (Holzer and Schneider, 1975; Miller and 
Magasanik, 1990). The synthesis of this enzyme is also re- 
pressed by glucose (Eraso and Gancedo, 1984) and this re- 
pression appears to depend on the presence of a repressing 
nitrogen source like glutamine (Coschigano et al., 1991). The 
cyc8 mutation allows a partial derepression of GDH2 in the 
presence of glucose but neither HXK2 nor HAP3 or HAP4 
appear to be involved in its regulation; other regulatory mu- 
tants which affect other systems subject to catabolite re- 
pression have not been tested. Two mutations rgcl and rgc2 
have been identified that block derepression of GDH2 in re- 
sponse to the carbon source. It is not yet known whether 
RGCl and RGC2 are allelic to previously described regulatory 
genes but it has been observed that the rgcl mutation does 
not affect the expression of CYCI or SUC2 and that rgc2, 
which causes a petite phenotype, does not interfere with the 
derepression of CYCl in raffinose. Deletion analysis of up- 
stream sequences of GDH2 delineated a region in the promoter 
involved in catabolite repression (Coschigano et al., 1991). 
The sequence of the promoter has just been reported (Miller 
and Magasanik, 1991) and a cursory examination reveals the 
presence of an element similar to those binding the regulatory 
protein MIGl. 
Protease B 
Protease B, a vacuolar serine protease encoded by the 
PRBI gene, is repressed by glucose (Hansen et al., 1977) at 
the level of transcription (Moehle et al., 1987). Mutations in 
the CATI, CAT3 or HXK2 genes had no effect on the regu- 
lation by glucose, while protease B expression increased in 
snf2 and snf5 mutants (Moehle and Jones, 1990). Although the 
moderate increase in expression (2 - 3-fold) is only partially 
coupled with an increase in mRNA level, it has been suggested 
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that SNF2 and SNF.5 are negative regulators of transcription 
for PRBI. An alternative interpretation of the results would 
be that SNF2 and SNF.5 are positive regulators of transcrip- 
tion of a regulatory gene (or genes) whose product interferes 
with the accumulation of protease B, either by decreasing 
PBRl  transcription or the stability of the PBRl mRNA or of 
the protease B itself. 
Mitochondria1 proteins 
The regulation of a set of mitochondrial proteins encoded 
by nuclear genes could proceed in parallel as shown by the 
fact that glucose decreases in a similar way the rate of tran- 
scription of the genes for the a and fl subunit of the ATPase 
and for an ATP/ADP translocator (Szekely and Montgomery, 
1984). A pet mutant has been identified in which these genes 
could not be derepressed while the transcription of the CYCl  
gene was not affected, the mutant however has not been 
characterized further (Szekely and Montgomery, 1984). 
The regulatory circuit controlling another nuclear gene 
encoding a mitochondria1 protein, PET494, also appears to 
be quite distinctive. The product of PET494 is required for 
the translation of the cox 111 mRNA which codes for the 
subunit I11 of cytochrome c oxidase (Miiller et al., 1984). 
PET494 expression is controlled by glucose and the degree of 
repression observed could account for the catabolite re- 
pression of cytochrome c oxidase. Using a PET494-lacZ 
fusion gene it could be shown that PET494 expression does 
not require the HAP2 product nor the products of CATl  or 
SNF2 and that glucose repression is not relieved in a cyc8 or 
hxk2 mutant (Marykwas and Fox, 1989). It has been suggested 
that PET494 regulation by carbon source may involve both 
transcriptional and post-transcriptional controls. 
Catalase A 
It has recently been reported that the CTAl  gene, which 
encodes catalase A, the peroxisomal catalase of S .  cerevisiae, 
and which is repressed by glucose, is regulated by the ADRl 
protein. This protein is also required for full derepression of 
other peroxisomal proteins (Simon et al., 1991). This obser- 
vation is interesting because it shows that a protein like ADRl 
which appeared to play a very specific function in the tran- 
scription of ADH2 has in fact pleiotropic effects. 
General features 
From the observations on the regulation of different genes 
discussed above, the following general features may be de- 
duced. 
a) Many regulatory trans-acting genes are shared by a 
variety of systems. Some elements, however, may have a nega- 
tive effect on a system and a positive one on another. For 
instance, eye8 null mutants lack catabolite repression of inver- 
tase and in a gal80 background also of a-gdlactosidase but 
they do not grow on non-fermentable carbon sources 
(Trumbly, 1988). This suggests that CYC8 can inhibit the 
transcription of certain genes but is required for the transcrip- 
tion of others. 
b) The regulatory circuits controlling different genes are 
very different and include a great variety of elements. 
c) Glucose acts in most cases by modifying the activity of 
trans-acting elements rather than their transcription rate. This 
explains why, for many systems, maximal repression of tran- 
scription is achieved a few minutes after the addition of glucose 
(Zitomer et al., 1979; Szekely and Montgomery, 1984). On 
the other hand, when total repression of transcription is only 
attained after 15 -20 min, as in the case of maltase (Fedoroff 
et al., 1983 b), glucose most likely affects the rate of transcrip- 
tion of a regulatory gene. 
d) Glucose appears to inhibit activating elements rather 
than activate inhibitory elements. In no case, however, has the 
whole sequence of events from glucose uptake to shut-down 
of transcription been unravelled. 
NON-SACCHA ROMYCES YEASTS 
Catabolite repression is particularly marked in facultative 
anaerobes such as S. cerevisiae but it is also found in aerobic 
yeasts like Rhodotorula, Debaryomyces or Pichia (Duntze et 
al., 1967; Gancedo and Gancedo, 1971). The information 
about mechanisms of catabolite repression in non-Saccharo- 
myces yeasts is still very scarce but hexokinase appears to be 
a mediator for the repression by glucose of at least a set of 
genes in different species like Schwanniomyces occidentalis 
(McCann et al., 1987) and Pachysolen tannophilus (Wedlock 
and Thornton, 1989). Mutants with a particular enzyme or 
pathway insensitive to glucose repression have been also iso- 
lated in Hansenula polymorpha (Roggenkamp, 1988) and in 
Schizosaccharomyces pombe (Hoffman and Winston, 1990). 
In the first case the mutants with non-repressible synthesis of 
enzymes involved in methanol oxidation also show a constitu- 
tive appearance of peroxisomes but have not been further 
characterized. For Schizosaccharomyces pombe, the mutants 
able to express fructose 1,6-bisphosphatase in the presence of 
glucose have been shown to belong to ten complementation 
groups that correspond to ten unlinked genes named git. The 
effect of six of the git mutations is reversed by the addition of 
CAMP to the growth medium and one of these genes, git2, 
encodes adenylate cyclase (Hoffman and Winston, 1991). 
Moreover, a mutant affected in the regulatory subunit of a 
CAMP-dependent protein kinase, cgsl (McLeod M., cited in 
Hoffman and Winston, 1991) does not derepress fructose 1,6- 
bisphosphatase. It would appear therefore that catabolite re- 
pression of this gene in Schizosaccharomyces pombe is related 
to the activation of a CAMP-dependent protein kinase 
(Hoffman and Winston, 1991). 
Some elements involved in yeast catabolite repression 
could be present in other fungi and even in plants. Recently, 
it has been reported that the product of the creA gene, a 
negatively acting regulator of catabolite repression in Asper- 
gillus nidulans, has 84% similarity in its zinc finger region 
with the MIGl protein from S. cerevisiae (Dowzer and Kelly, 
1991). A gene isolated from rye endosperm and coding for a 
protein kinase has been shown to perform in yeast the same 
function as the CATl product. A comparison of the 80 residues 
in the central catalytic domain of each protein shows that 
69 are identical and 6 represent conservative substitutions 
(Alderson et al., 1991). 
PERSPECTIVES 
I have shown in this review the impressive amount of 
information on catabolite repression gathered in the last few 
years. In spite of it, our knowledge on how glucose represses 
transcription still remains fragmentary. The availability of a 
system for in vitro transcription will be of great importance to 
identify the elements which control gene expression in yeast, 
as happened in the case of E.  coli. In the case of yeast, tran- 
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Table 8. Bias introduced by the selection procedures in the search for catabolite repression mutants. 
Selection method Mutants found Mutants expected Reference 
High invertase in cells grown on 12 cyc8 1 tupl cyc8 tupl hxk2 hex2 cat80 migl Trumbly 1986 
10% glucose rgr I 
Revertants from catl and cat3 mostly cat4 
growing on raffnose or maltose 
Expression on glucose of 
GALCHIS 3 
cat80 cyc8 tupl 
cyc8 tupl Schiiller & Entian 1991 
cyc8 tupl hxk2 hex2 migl gal82 
gal83 
Griggs & Johnston 1991 
Expression on glucose + galactose 
Anaerobic growth on sucrose 
Growth on galactose or sucrose 
No expression of CYCI-lacZ hap2 hap3 hap4 hap2 hap3 hap4 catl Forsburg & Guarente 1989 
from 15 recessive mutants, 
140 hex2 40hxk2 21 cidl 
9 others (no cyc8 no tup l )  
600 mutants: hxk2 hex2 or 
cat80 cyc8 tupl hxk2 hex2 migl 
hex2 hxk2 cyc8 tupl cat80 migl 
rgr 1 
hex2 hxk2 cyc8 tupl cat80 migl 
Flick & Johnston 1991 
of GALl-HIS3 and GAL1-lacZ 7 cat80 gal82 gal83 
Neigeborn & Carlson 1987 
+ 2 deoxyglucose 
Zimmermann & Scheel 1977, 
+ 2 deoxyglucose cat80 rgr I Entian & Zimmermann 1980 
scription in vitro presented for years insoluble problems; how- 
ever, reliable procedures have been established recently (Lue 
et al., 1989) and the possibility now exists to perform direct 
experiments to test the effects of different intermediary el- 
ements. However, due to the fact that naked templates are used 
in vitro and to the complexity of the transcription machinery, it 
is not yet clear if regulated transcription can be faithfully 
reconstituted in vitro. Therefore it appears that for some time 
in the future the isolation and analysis of mutants will still be 
an important tool in the study of catabolite repression. In this 
regard it should be considered that the selection of mutants is 
complicated by the fact that, for reasons not well understood, 
each selection procedure tends to yield only a limited number 
of mutant alleles (Trumbly, 1986, Schiiller and Entian, 1991). 
As can be seen in Table 8, selection conditions which should 
have allowed the isolation of a variety of mutants produced 
only a limited set. It is thus likely that there are still genes 
involved in catabolite repression which have not been identi- 
fied. To detect them, it is necessary to devise selection pro- 
cedures that should be both powerful and unbiased. The possi- 
bility that some of the regulatory proteins yet undiscovered 
could have pleiotropic effects should be taken into account 
and therefore the search for conditional mutants should be 
considered. The use of fusion genes in which the reporter 
gene allows a growth selection or an easy on-plate test could 
circumvent some of the difficulties, although the procedure is 
in some cases hampered by technical problems. 
The study of mutants affected in the very early steps of 
glucose metabolism could be a good starting point in the 
search for the signal produced by glucose. The possibility that 
different systems are controlled by different signals should not 
be overlooked and therefore a diversity of systems should be 
examined in the search for the mode of action of glucose. 
Also, to detect whether glucose affects the synthesis of some 
intermediary elements, it could be useful to investigate the 
effect of inhibitors of protein synthesis on the onset of re- 
pression or derepression. 
An important point to keep in mind when studying 
catabolite repression is the possible relationship between the 
glucose effect in yeast and the effects of growth factors in 
mammalian cells. In many aspects glucose can be considered 
to be a growth factor for a yeast cell and it could be speculated 
that some elements have been evolutionarily conserved in 
the different systems. Glucose activation of the yeast plasma 
membrane proton ATPase and the subsequent acidification 
of the cytoplasm can be put in parallel with the fact that an 
early response of eukaryotic cells to stimuli which activate 
their proliferation is an increase in intracellular pH (Perona 
and Serrano, 1988). The HAP2/HAP3/HAP4 system has its 
counterpart in the CCAAT box-binding factors CP1 A and 
CPIB from HeLa cells (Chodosh et al., 1988) and the MIGI 
protein has a CyszHisz Zn finger similar to that of the Wilms 
tumour protein and to that of proteins encoded by early 
growth-response genes (Nehlin and Ronne, 1990). It is there- 
fore not too far-fetched to think that some of the regulatory 
mechanisms used for catabolite repression in yeast have been 
conserved in higher organisms and utilized for growth control. 
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